ARTICLE | Product Development
Three CEPI-funded vaccines secure additional manufacturing resources
AZ awarded first advanced market commitment for COVID-19 vaccine
June 5, 2020 2:53 AM UTC
Three CEPI-funded vaccines secured additional manufacturing resources Thursday in a trio of announcements that included the first advanced market commitment from the ACT Accelerator to supply COVID-19 vaccines to low and middle-income countries at no cost.
AstraZeneca plc (LSE:AZN; NYSE:AZN) will receive $750 million from the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, to support the manufacturing and distribution of 300 million doses of AZD1222 (formerly ChAdOx1 nCoV-19). The first doses of the vaccine, which the pharma licensed from the University of Oxford, will be delivered by year-end. ...